QS Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,567
| Closed | -$241K | – | 1266 |
|
|
2020
Q3 | $241K | Sell |
9,567
-47,522
| -83% | -$1.2M | ﹤0.01% | 1006 |
|
|
2020
Q2 | $1.4M | Sell |
57,089
-200
| -0.3% | -$4.89K | 0.02% | 625 |
|
|
2020
Q1 | $848K | Sell |
57,289
-293
| -0.5% | -$4.34K | 0.01% | 710 |
|
|
2019
Q4 | $922K | Sell |
57,582
-4,072
| -7% | -$65.2K | 0.01% | 798 |
|
|
2019
Q3 | $802K | Sell |
61,654
-71
| -0.1% | -$924 | 0.01% | 830 |
|
|
2019
Q2 | $801K | Sell |
61,725
-1,436
| -2% | -$18.6K | 0.01% | 862 |
|
|
2019
Q1 | $996K | Hold |
63,161
| – | – | 0.01% | 813 |
|
|
2018
Q4 | $1.27M | Hold |
63,161
| – | – | 0.02% | 704 |
|
|
2018
Q3 | $1.57M | Hold |
63,161
| – | – | 0.02% | 687 |
|
|
2018
Q2 | $1.73M | Buy |
63,161
+5
| +0% | +$137 | 0.02% | 639 |
|
|
2018
Q1 | $1.95M | Sell |
63,156
-5,303
| -8% | -$163K | 0.02% | 592 |
|
|
2017
Q4 | $2.45M | Sell |
68,459
-3,407
| -5% | -$122K | 0.02% | 537 |
|
|
2017
Q3 | $1.98M | Buy |
71,866
+12,607
| +21% | +$347K | 0.02% | 611 |
|
|
2017
Q2 | $1.56M | Buy |
+59,259
| New | +$1.56M | 0.01% | 652 |
|
|
2016
Q1 | – | Sell |
-10,800
| Closed | -$369K | – | 2078 |
|
|
2015
Q4 | $369K | Buy |
+10,800
| New | +$369K | ﹤0.01% | 959 |
|